Background: Leprosy and tuberculosis are two of the oldest and most common mycobacterial infections, caused by and for leprosy and for tuberculosis. Dual infections have been known since ancient times; however, cases remain rarely reported in the literature, even in countries where both diseases are endemic, such as Madagascar.
Purpose: We report a case series of simultaneous occurrence of leprosy and tuberculosis.
Introduction: Chromoblastomycosis (CBM) is a chronic fungal infection of the skin and subcutaneous tissue caused by several pigmented fungi. It is frequently found in tropical and subtropical areas like Madagascar. This study primarily discusses the effects of antifungal therapy while also describing the epidemiological, clinical, and pathological features of CBM in our patients.
View Article and Find Full Text PDFInt J Womens Dermatol
December 2021
Lupus erythematosus (LE) is a chronic autoimmune disease that affects more women than men. The quality of life (QoL) of patients with lupus erythematosus and skin manifestations is impaired, but little is known about Malagasy patients. This study aimed to assess the impact of cutaneous lesions on the QoL of patients who present with LE.
View Article and Find Full Text PDFBackground: Although atopic dermatitis (AD) is becoming a pressing public health concern in the world, Madagascar is underrepresented in the AD literature.
Objective: We aimed to study the demographic and clinical pattern of AD in adult dermatology outpatients.
Methods: A cross-sectional study was conducted in the Department of Dermatology, University Hospital, Antananarivo, Madagascar.
Sporotrichosis is a frequent subcutaneous mycosis in Madagascar. Extracutaenous forms are exceptional and are usually seen in immunosuppressed hosts. We report a case of an aggressive clinical evolution of lymphocutaneous sporotrichosis with osteoarticular involvement in an immunocompetent patient.
View Article and Find Full Text PDFBackground: Psoriasis is a chronic, inflammatory, and multifactorial dermatosis that impairs quality of life (QoL). Health-related QoL has become an important element in medical decision-making along with the effectiveness and the harmlessness of the treatments.
Objective: To assess the impact of psoriasis in the QoL of patients with psoriasis by using the DLQI scales.
Objective: To describe the clinical aspects of chromoblastomycosis (CBM) presented by patients who had received incomplete antifungal treatment before consultation.
Methods: A prospective study of patients with clinically suspected CBM was performed between 2013 and 2018 in the Department of Dermatology at the University Hospital Antananarivo, and during consultation campaigns.
Results: Patients develop CBM over a period of more than 10 years, and many will have already received antifungals prescribed by general practitioners before consulting with a dermatologist.